<DOC>
	<DOCNO>NCT00153075</DOCNO>
	<brief_summary>The objective trial compare total regional deposition aerosol lung oropharynx patient COPD 3 different inspiratory flow rate follow inhalation Berodual deliver via Respimat inhaler Berodual ? deliver via HFA-metered dose inhaler .</brief_summary>
	<brief_title>Flow Rate Effect Respimat Inhaler Versus Metered Dose Inhaler Using Berodual Patients With Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description>This single dose , randomise , active-controlled , six period , open-label cross-over trial adult patient COPD . Berodual ( fenoterol hydrobromide 50 g + ipratropium bromide 20 g ) deliver via Respimat inhaler MDI 3 different inspiratory flow rate : 15 L/min , 30 L/min 90 L/min . The optimal flow rate expect 30 L/min inhaler . On test day patient practise inhalation manoeuvre either placebo Respimat MDI inhaler . When patient perform inhalation technique correctly obtain required inspiratory flow rate placebo replace radio-labelled formulation . The primary analysis carry use Sign Test . This non-parametric analysis assumption make shape distribution response Respimat inhaler MDI null hypothesis . Study Hypothesis : The null hypothesis flow rate effect Respimat MDI inhaler . The alternative hypothesis flow rate different effect Respimat inhaler MDI inhaler . This mean null hypothesis median difference Respimat inhaler MDI pair zero i.e. , difference equally lik ely positive negative . Under alternative hypothesis median difference Respimat inhaler MDI pair zero i.e. , frequency positive negative sign different . Comparison ( ) : For primary comparison whole lung deposition achieve patient 90 L/min flow rate express percentage whole lung deposition achieve patient 30 L/min flow rate Respimat MDI inhaler separately . The difference pair observation ( ( Respimat 90 L/min / Respimat 30 L/min ) - ( MDI 90 L/min / MDI 30 L/min ) ) calculate sign direction difference note i.e. , positive negative . The probability associate occurrence observe number positive negative difference determine reference binomial distribution probability positive negative difference equal 0.5 null hypothesis . If alternative hypothesis , however , true flow rate fact le effect Respimat inhaler MDI inhaler , likely statistically significant great number positive difference .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Fenoterol , ipratropium drug combination</mesh_term>
	<mesh_term>Fenoterol</mesh_term>
	<mesh_term>Ipratropium</mesh_term>
	<criteria>COPD patient : FEV1 le equal 65 % pre FEV1 le equal 70 % FVC Patients upper respiratory infection past 14 day prior Screening Visit ( Visit 1 ) Patients unstable lifethreatening cardiac arrhythmia</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>